| ClinicalTrials.gov Identifier: |
NCT01697072 |
| Brief Title: |
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma (RILOMET-1) |
|
|
First Submitted : |
September 26, 2012 |
|
First Submitted that Met QC Criteria : |
September 28, 2012 |
|
First Posted : |
October 2, 2012
(Estimate)
|
|
|
Certification/Extension First Submitted : |
October 22, 2015 |
|
Certification/Extension First Submitted that Met QC Criteria :
|
October 22, 2015 |
|
Certification/Extension First Posted : |
November 13, 2015
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
January 18, 2016 |
|
Last Update Posted : |
February 9, 2016
(Estimate)
|
|
